Metropolitan Dermatology Introduces Nevisense® Technology for Advanced Melanoma Detection
Metropolitan Dermatology Introduces Nevisense® Technology for Advanced Melanoma Detection
Publish Date: 2026-06-08 08:37:00
Source Domain: www.prnewswire.com
Now available in Newton, Clark, and Vineland locations
CLARK, N.J., June 8, 2026 /PRNewswire/ — Metropolitan Dermatology is proud to announce the addition of Nevisense®, a cutting-edge, non-invasive melanoma detection technology, now available at its Newton, Clark, and Vineland offices. With this advancement, Metropolitan Dermatology is currently the only practice in NJ offering this innovative diagnostic tool.
Dr. Alex Doctoroff, CEO, Medical Director
Nevisense® utilizes electrical impedance spectroscopy (EIS) to analyze suspicious moles beneath the skin’s surface, providing physicians with an additional layer of information beyond what can be seen visually. This advanced technology enhances clinical decision-making and supports earlier, more accurate detection of melanoma—the deadliest form of skin cancer.
“Early detection is critical when it comes to melanoma,” said Dr. Alex Doctoroff, CEO and Medical Director, at Metropolitan Dermatology. “By incorporating Nevisense® into our practice, we are giving our patients access to one of the most advanced diagnostic tools available today, improving both accuracy and peace of mind.”
Key Advantages of Nevisense® Include:
- Non-invasive and painless evaluation of suspicious lesions
- Improved diagnostic accuracy when used alongside visual examination and dermoscopy
- Reduction in unnecessary biopsies, helping patients avoid discomfort and scarring
- Early detection support, which is critical for successful melanoma treatment outcomes
Nevisense® is…
